Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2002 Mar;39(3):178–183. doi: 10.1136/jmg.39.3.178

Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas

B Baysal 1, J Willett-Brozick 1, E Lawrence 1, C Drovdlic 1, S Savul 1, D McLeod 1, H Yee 1, D Brackmann 1, W Slattery 1, E Myers 1, R Ferrell 1, W Rubinstein 1
PMCID: PMC1735061  PMID: 11897817

Abstract

Background: Paragangliomas are rare and highly heritable tumours of neuroectodermal origin that often develop in the head and neck region. Germline mutations in the mitochondrial complex II genes, SDHB, SDHC, and SDHD, cause hereditary paraganglioma (PGL).

Methods: We assessed the frequency of SDHB, SDHC, and SDHD gene mutations by PCR amplification and sequencing in a set of head and neck paraganglioma patients who were previously managed in two otolaryngology clinics in the USA.

Results: Fifty-five subjects were grouped into 10 families and 37 non-familial cases. Five of the non-familial cases had multiple tumours. Germline SDHD mutations were identified in five of 10 (50%) familial and two of 37 (∼5%) non-familial cases. R38X, P81L, H102L, Q109X, and L128fsX134 mutations were identified in the familial cases and P81L was identified in the non-familial cases. Both non-familial cases had multiple tumours. P81L and R38X mutations have previously been reported in other PGL families and P81L was suggested as a founder mutation. Allelic analyses of different chromosomes carrying these mutations did not show common disease haplotypes, strongly suggesting that R38X and P81L are potentially recurrent mutations. Germline SDHB mutations were identified in two of 10 (20%) familial and one of 33 (∼3%) non-familial cases. P131R and M71fsX80 were identified in the familial cases and Q59X was identified in the one non-familial case. The non-familial case had a solitary tumour. No mutations could be identified in the SDHC gene in the remaining four families and 20 sporadic cases.

Conclusions: Mutations in SDHD are the leading cause of head and neck paragangliomas in this clinic patient series. SDHD and SDHB mutations account for 70% of familial cases and ∼8% of non-familial cases. These results also suggest that the commonness of the SDHD P81L mutation in North America is the result of both a founder effect and recurrent mutations.

Full Text

The Full Text of this article is available as a PDF (144.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arias-Stella J., Valcarcel J. Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance. Hum Pathol. 1976 Jul;7(4):361–373. doi: 10.1016/s0046-8177(76)80052-4. [DOI] [PubMed] [Google Scholar]
  2. Astuti D., Latif F., Dallol A., Dahia P. L., Douglas F., George E., Sköldberg F., Husebye E. S., Eng C., Maher E. R. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001 Jun 12;69(1):49–54. doi: 10.1086/321282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Badenhop R. F., Cherian S., Lord R. S., Baysal B. E., Taschner P. E., Schofield P. R. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer. 2001 Jul;31(3):255–263. doi: 10.1002/gcc.1142. [DOI] [PubMed] [Google Scholar]
  4. Baysal B. E., Farr J. E., Rubinstein W. S., Galus R. A., Johnson K. A., Aston C. E., Myers E. N., Johnson J. T., Carrau R., Kirkpatrick S. J. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet. 1997 Jan;60(1):121–132. [PMC free article] [PubMed] [Google Scholar]
  5. Baysal B. E., Ferrell R. E., Willett-Brozick J. E., Lawrence E. C., Myssiorek D., Bosch A., van der Mey A., Taschner P. E., Rubinstein W. S., Myers E. N. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000 Feb 4;287(5454):848–851. doi: 10.1126/science.287.5454.848. [DOI] [PubMed] [Google Scholar]
  6. Baysal B. E., Willett-Brozick J. E., Taschner P. E., Dauwerse J. G., Devilee P., Devlin B. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. Eur J Hum Genet. 2001 Feb;9(2):121–129. doi: 10.1038/sj.ejhg.5200585. [DOI] [PubMed] [Google Scholar]
  7. Baysal B. E., van Schothorst E. M., Farr J. E., Grashof P., Myssiorek D., Rubinstein W. S., Taschner P., Cornelisse C. J., Devlin B., Devilee P. Repositioning the hereditary paraganglioma critical region on chromosome band 11q23. Hum Genet. 1999 Mar;104(3):219–225. doi: 10.1007/s004390050939. [DOI] [PubMed] [Google Scholar]
  8. Drovdlic C. M., Myers E. N., Peters J. A., Baysal B. E., Brackmann D. E., Slattery W. H., 3rd, Rubinstein W. S. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope. 2001 Oct;111(10):1822–1827. doi: 10.1097/00005537-200110000-00029. [DOI] [PubMed] [Google Scholar]
  9. Gimm O., Armanios M., Dziema H., Neumann H. P., Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res. 2000 Dec 15;60(24):6822–6825. [PubMed] [Google Scholar]
  10. Grufferman S., Gillman M. W., Pasternak L. R., Peterson C. L., Young W. G., Jr Familial carotid body tumors: case report and epidemiologic review. Cancer. 1980 Nov 1;46(9):2116–2122. doi: 10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  11. Heutink P., van Schothorst E. M., van der Mey A. G., Bardoel A., Breedveld G., Pertijs J., Sandkuijl L. A., van Ommen G. J., Cornelisse C. J., Oostra B. A. Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet. 1994;2(3):148–158. doi: 10.1159/000472358. [DOI] [PubMed] [Google Scholar]
  12. Heutink P., van der Mey A. G., Sandkuijl L. A., van Gils A. P., Bardoel A., Breedveld G. J., van Vliet M., van Ommen G. J., Cornelisse C. J., Oostra B. A. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet. 1992 Apr;1(1):7–10. doi: 10.1093/hmg/1.1.7. [DOI] [PubMed] [Google Scholar]
  13. Lack E. E. Hyperplasia of vagal and carotid body paraganglia in patients with chronic hypoxemia. Am J Pathol. 1978 Jun;91(3):497–516. [PMC free article] [PubMed] [Google Scholar]
  14. Mariman E. C., van Beersum S. E., Cremers C. W., van Baars F. M., Ropers H. H. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet. 1993 May;91(4):357–361. doi: 10.1007/BF00217356. [DOI] [PubMed] [Google Scholar]
  15. Milunsky J. M., Maher T. A., Michels V. V., Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet. 2001 May 15;100(4):311–314. doi: 10.1002/ajmg.1270. [DOI] [PubMed] [Google Scholar]
  16. Milunsky J., DeStefano A. L., Huang X. L., Baldwin C. T., Michels V. V., Jako G., Milunsky A. Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet. 1997 Oct 3;72(1):66–70. doi: 10.1002/(sici)1096-8628(19971003)72:1<66::aid-ajmg14>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  17. Niemann S., Becker-Follmann J., Nürnberg G., Rüschendorf F., Sieweke N., Hügens-Penzel M., Traupe H., Wienker T. F., Reis A., Müller U. Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma. Am J Med Genet. 2001 Jan 1;98(1):32–36. [PubMed] [Google Scholar]
  18. Niemann S., Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000 Nov;26(3):268–270. doi: 10.1038/81551. [DOI] [PubMed] [Google Scholar]
  19. Petropoulos A. E., Luetje C. M., Camarata P. J., Whittaker C. K., Lee G., Baysal B. E. Genetic analysis in the diagnosis of familial paragangliomas. Laryngoscope. 2000 Jul;110(7):1225–1229. doi: 10.1097/00005537-200007000-00030. [DOI] [PubMed] [Google Scholar]
  20. Taschner P. E., Jansen J. C., Baysal B. E., Bosch A., Rosenberg E. H., Bröcker-Vriends A. H., van Der Mey A. G., van Ommen G. J., Cornelisse C. J., Devilee P. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer. 2001 Jul;31(3):274–281. doi: 10.1002/gcc.1144. [DOI] [PubMed] [Google Scholar]
  21. van Schothorst E. M., Jansen J. C., Bardoel A. F., van der Mey A. G., James M. J., Sobol H., Weissenbach J., van Ommen G. J., Cornelisse C. J., Devilee P. Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes. Eur J Hum Genet. 1996;4(5):267–273. doi: 10.1159/000472213. [DOI] [PubMed] [Google Scholar]
  22. van der Mey A. G., Maaswinkel-Mooy P. D., Cornelisse C. J., Schmidt P. H., van de Kamp J. J. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet. 1989 Dec 2;2(8675):1291–1294. doi: 10.1016/s0140-6736(89)91908-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES